Search

everythinglearnresearchcommunity

for

Search:↓

Estetrol helps keep scalp hair in the growth phase longer and improves hair follicle health by affecting the hair root and increasing stem cells.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Tamoxifen caused hair loss in a 52-year-old woman.

γ‐Oryzanol ointment increases sebaceous gland activity and sebum production.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Testosterone changes how certain channels work in male rat reproductive tracts, affecting fertility-related fluid balance.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

Lifestyle changes improve symptoms and fertility in hyper-androgenic women.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

The E2 protein affects gene activity in hair follicles of mice.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.